Safe, Effective, and More Tolerable 16 Tablets Colon Prep (ABP)
|ClinicalTrials.gov Identifier: NCT00817934|
Recruitment Status : Unknown
Verified January 2009 by Long Neck Medical Enterprises.
Recruitment status was: Active, not recruiting
First Posted : January 7, 2009
Last Update Posted : January 7, 2009
|Condition or disease||Intervention/treatment|
|Colon Cancer||Drug: AB PREP|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Phase III of the AB Prep Safety and Efficacy in Colon Cleansing|
|Study Start Date :||January 2009|
|Estimated Primary Completion Date :||January 2010|
|Estimated Study Completion Date :||January 2010|
PREVENTION AND TREATMENT
PATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50.
Drug: AB PREP
Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).
Other Name: Reglan, K-Phos neutral, and Dulcolax
- TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY [ Time Frame: IMMEDIATE, DURING THE COLONOSCOPY ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00817934
|United States, Delaware|
|Cedar Tree Surgical Center|
|Millsboro, Delaware, United States, 19966|
|Principal Investigator:||SEMAAN M ABBOUD, MD|